Year None 2026 2025 2024 2023 2022 2021 2020 2019 2016 2015 2014 2006 Sep 29, 2026 CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026 Sep 21, 2026 CVRx Appoints John Landry as Chief Financial Officer Aug 25, 2026 CVRx Responds to Letter from Pointillist Family Office Aug 24, 2026 CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy Aug 11, 2026 CVRx Announces Sales Leadership Transition Aug 06, 2026 CVRx Reports Second Quarter 2026 Financial and Operating Results Jul 28, 2026 CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference Jul 23, 2026 CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026 Jun 09, 2026 CVRx Announces Chief Financial Officer Transition May 27, 2026 CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference Pagination Current page 1 Page 2 Page 3 Next page next Last page last Displaying 1 - 10 of 23
